In the latest session, OPKO Health Inc. (NASDAQ: OPK) closed at $1.34 up 7.20% from its previous closing price of $1.25. In other words, the price has increased by $+0.0900 from its previous closing price. On the day, 5059997 shares were traded. OPK stock price reached its highest trading level at $1.3500 during the session, while it also had its lowest trading level at $1.2500.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
For a deeper understanding of OPKO Health Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 15, 2022, initiated with a Buy rating and assigned the stock a target price of $3.
On June 21, 2021, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $7.Ladenburg Thalmann initiated its Buy rating on June 21, 2021, with a $7 target price.
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 08 when FROST PHILLIP MD ET AL bought 1,000,000 shares for $1.18 per share. The transaction valued at 1,175,384 led to the insider holds 199,831,694 shares of the business.
OPKO HEALTH, INC. bought 14,285,714 shares of OPK for $5,000,000 on Jan 26. The 10% Owner now owns 94,285,714 shares after completing the transaction at $0.35 per share. On Nov 22, another insider, FROST PHILLIP MD ET AL, who serves as the CEO & Chairman of the company, bought 300,000 shares for $1.49 each. As a result, the insider paid 446,673 and bolstered with 198,831,694 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.01 while its Price-to-Book (P/B) ratio in mrq is 0.64.
Stock Price History:
Over the past 52 weeks, OPK has reached a high of $3.78, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is 1.2678, while the 200-Day Moving Average is calculated to be 1.8865.
For the past three months, OPK has traded an average of 3.23M shares per day and 6.57M over the past ten days. A total of 751.88M shares are outstanding, with a floating share count of 416.76M. Insiders hold about 0.40% of the company’s shares, while institutions hold 24.70% stake in the company. Shares short for OPK as of Jan 12, 2023 were 37.44M with a Short Ratio of 37.62M, compared to 36.77M on Dec 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.85% and a Short% of Float of 8.89%.
There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.16, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.06 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.42 and -$0.51 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.23, with 6 analysts recommending between $0.13 and -$0.45.
A total of 6 analysts believe the company’s revenue will be $168.21M this quarter.It ranges from a high estimate of $177.7M to a low estimate of $163M. As of the current estimate, OPKO Health Inc.’s year-ago sales were $401.3M, an estimated decrease of -58.10% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $174.31M, a decrease of -47.10% over than the figure of -$58.10% in the same quarter last year. There is a high estimate of $183.06M for the next quarter, whereas the lowest estimate is $168.3M.
A total of 6 analysts have provided revenue estimates for OPK’s current fiscal year. The highest revenue estimate was $995.2M, while the lowest revenue estimate was $981.86M, resulting in an average revenue estimate of $986.83M. In the same quarter a year ago, actual revenue was $1.77B, down -44.40% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $832.27M in the next fiscal year. The high estimate is $1.09B and the low estimate is $719.1M. The average revenue growth estimate for next year is down -15.70% from the average revenue estimate for this year.